Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
5,594 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
JPMorgan initiates SPX Technologies with an Overweight rating and a $260 target, signalling a favorable view on data-...
Marvell Technology is poised to release earnings later this week, with investors focused on AI chip orders and optica...
Investors are watching a potential defense-spending surge as the iran conflict could feed new arms orders, lifting de...
February brought an 11% slide in main street capital stock as investors weighed private credit risk and rising rates....
Palantir stock surging today has investors buzzing about what comes next. This article breaks down the catalysts, the...
Two popular fixed-income ETFs, LQD and TLT, offer very different paths to income and risk. This guide explains why LQ...
A major AI cloud deal sparked a notable move in CoreWeave stock on Wednesday. This article explains what happened, wh...
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Turnaround stories can spark excitement, but income-focused investors should seek a true dividend top dog. This artic...
Dogecoin has sparked fresh headlines with notable price moves. Before you jump in, learn how to assess the momentum, ...
As AI demand soars, Micron sits at the center of memory hardware used in data centers. This article breaks down wheth...